Primordial Genetics Inc.

We are a synthetic biology company developing superior enzymes for manufacturing RNA and DNA, key ingredients in pharmaceutical, diagnostic and R&D products.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded November 2011
  • Employees 7
  • Incorporation Type C-corp
  • Website primordialgenetics.com

Company Summary

Primordial Genetics is a synthetic biology company with genetic technology enabling dramatic performance improvements in enzymes & microbes used to produce high-value compounds. We are developing superior enzymes for manufacturing RNA and DNA, the biological carriers of genetic information that are critical enablers of the biotechnology industry and key ingredients in numerous pharmaceutical, diagnostic and R&D products.

Team

  • Founder and President

    Biotechnology professional and entrepreneur with extensive experience in technology development, R&D project leadership and IP development/management in early-stage biotechnology companies. Founded Primordial Genetics in 2011 with the goal of building the premier company for enzyme development and microbial strain improvement. Helped launch multiple biotech startups including Akkadix, Chromatin, Synthetic Genomics, Agradis, and Industry3200.

  • Michele Rubino
    Chief Business Officer

    Business professional with an extensive track record in biotechnology, biofuels and cleantech. Previously COO and Board Member of Beta Renewables, a JV between MG Chemicals, Novozymes and Private Equity TPG, focused on commercializing technology for the conversion of lignocellulosic biomass to biofuels and bio-based chemicals. As business developer at Synthetic Genomics secured landmark partnership with ExxonMobil in algae biofuels.

  • Karen Xu
    Director, Biologicals Development

    Scientific leader in the biotechnology industry with an expertise in microbiology, molecular biology, protein purification, biochemistry and synthetic biology. Held various scientific positions at Diversa Corporation, Genlantis and Synthetic Genomics with responsibilities and project oversight in microbial discovery, pathway discovery and product development for agricultural, nutritional and biopolymer production applications.

  • Daniel Olson
    Senior Scientist

    Highly creative geneticist and biochemist with expertise in microbial genetics, genome engineering, biochemistry, and cell biology. Extensive experience with yeast genetics, biochemistry and strain development. Strong track record in enzyme improvement using Primordial Genetics’ proprietary technologies. Previously directed a metagenomic and metatranscriptomic analysis of marine microbial community metabolism.

  • Alan Greener
    Research Fellow

    Highly experienced bacterial geneticist and scientist/inventor with 25 years’ work history in bacterial strain development, protein expression systems and the development of diverse Life Science R&D tools; formerly Vice President, R&D at Genlantis (Gene Therapy Systems Inc.) and Program Director, Stratagene Inc.

  • Sabrina Baffert
    Project manager and Senior Research Associate

    Biotechnology professional with >10 years’ experience in molecular biology, microbial genetics & genomics and technology development. Sabrina has worked on various industrial biotechnology collaborations focusing on pharmaceutical, renewable fuels and agricultural applications. Sabrina has managed several industrial collaborations applying Primordial Genetics’ Function Generator technology to strain improvement and enzyme development.

  • Brian Vaughan
    Staff Scientist

    Biotechnologist and scientist with >16 years’ experience leading industrial and agricultural biotechnology programs for Life Technologies, Monsanto and Bayer. At Monsanto/Bayer he was part of a microbial crop improvement project and built a microbial genome sequencing pipeline for over 10,000 microbial strains per year. He has vast experience with Next Generation Sequencing, assay development, automation development and high throughput screening.

Advisors

  • J. Todd Mitchell
    Unconfirmed
    Dominick Mendola
    Unconfirmed

Previous Investors

  • Walton Mitchell & Company
    Unconfirmed
    Two Seven Ventures
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free